Crowdfunding
Mamacrowd Launches Five Campaigns with November 10th Deadline
To date, no Italian platform has obtained European authorization, so platforms cannot operate after November 10th. In the uncertainty, Mamacrowd has preferred to advise companies to launch their rounds in these days and to close them by the last date when the old regulation will be in force. A scenario that generates a crowding of investment proposals, is anomalous for Italian crowdfunding.
The Italian authority (Consob and Banca D’Italia) has reportedly mandated that campaigns launched under the old equity crowdfunding regulatory regime cannot be online after November 10th, the deadline for the new European crowdinvesting regulation to come into effect.
Mamacrowd has therefore decided, in agreement with the proponents, to launch as many as five equity crowdfunding campaigns, all with a November 10th deadline, to avoid any possible regulatory problems.
To date, no Italian platform has yet obtained European authorization, and that, in its absence, platforms cannot operate after November 10th.
In the uncertainty, Mamacrowd has therefore preferred to advise companies to launch their rounds in these days and to close them by the last date when the old regulation will be in force.
A scenario that generates a crowding of investment proposals, is anomalous for Italian crowdfunding, especially given the current moment of macroeconomic difficulty.
Read more about the latest campaigns launched on Mamacrowd and find the most important business news of the day with our companion app Born2Invest.
Mealthie’s campaign on Mamacrowd
Specializing in Healthy Food, Mealthie is an innovative startup founded in Milan in 2021, with the aim of proposing fresh, balanced, and high-quality dishes. A philosophy that puts health first for those who believe that wellness begins at the table.
Between 2021 and 2022, Mealthie increased its turnover by 200 percent, from €215,000 to €676,000. A goal that it expects to exceed further in 2023, with the target set at €1.2 million.
The round is aiming for a minimum fundraising target of €150,000 with a pre-money valuation of €5.3 million.
Biova Project on Mamacrowd
Biova Project was created to give a second life to surplus food that is in danger of becoming waste. Created in 2019, Biova chose beer as its first product to test its model in the market: a range of beers created to combat food waste, extracted from unsold bread, pasta scraps, and broken rice. From 150 kg of unsold bread, 2,500 liters of craft beer are produced, saving 30 percent of virgin raw materials.
To date, Biova’s products can be found on the shelves of major Ho.re.ca chains and also in large-scale retail chains such as COOP Nord Ovest and Carrefour, on Cortilia, and at many other distributors. Thanks to successful partnerships, chains such as Capatoast (40 restaurants) and Ikea Italia (22 restaurants and bars) are also served. The products are also having a good response in luxury hotels (Melia, Mandarin Oriental, Nh, Radisson).
Biova is in its third equity crowdfunding round and is aiming for a minimum fundraising target of €500,000 with a pre-money valuation of €6 million.
Jamin
Jamin Portofino UnderWaterWines, a benefit company, is an innovative SME specializing in providing engineering services for underwater refinement technologies and methodologies. Its environmentally sustainable method is applicable to wine, spirits, and other food products in a liquid state. Currently, its membership model constitutes the only international network of underwater wineries.
After the experience gained with the private label-oriented Jamin 1.0 model, the company has inaugurated Jamin 2.0, which is predominantly B2B and complements its predecessor. Jamin allows any entrepreneur to independently open their own underwater winery.
Jamin is in its second equity crowdfunding round. In the first campaign, it had raised €600,000 thanks to 270 investors, while in this round, and is aiming for a minimum fundraising goal of €200,000 with a pre-money valuation of €4.3 million.
Paesano
Paesano is an innovative startup whose spirits target the world of hotels and cocktail bars. It uses only raw materials with certified provenance, combining the tradition of Sicily with innovation learned through research and development studies in the field of food biotechnology.
The uniqueness of Paesano’s liqueurs and the marked distinction with competitors lie in the use of highly concentrated ingredients (up to 50 percent fruit in total recipes).
To date, Paesano has sold more than 40,000 bottles and has business relationships with 16 nations, 13 European as well as Switzerland, the United Kingdom, and the United States, with foreign sales accounting for 65 percent of total sales.
The company is aiming for a minimum fundraising target of €80,000 with a pre-money valuation of €1.8 million.
Wikipoint
Wikipoint is a B2B2C platform that realizes the 3D Solidarity Social Network. The mission is to enable the creation of a new channel of digital presence through the faithful reconstruction of iconic real-world locations (New York, Paris, Rome, Milan, and many others).
In the platform, SMEs find an effective way to manage the fundamental issues that are part of a Digital Marketing strategy, such as visibility to users, creation of new contacts (lead generation), and online sales. A comprehensive suite of tools that can be used both inside and outside the virtual 3D world.
Wikipoint is in its second round of equity crowdfunding. In the first campaign, it had raised €672,000 thanks to 309 investors, while in this round, and is aiming for a minimum fundraising goal of €100,000 with a pre-money valuation of €6.49 million.
__
(Featured image by geralt via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Markets1 week ago
Markets Surge on Trump Victory—But Can Overvaluation and Recession Risks Stall the Rally?
-
Biotech2 days ago
Sanofi Injects 40 Million Euros to Strengthen Its Production in France
-
Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
-
Biotech2 weeks ago
Leitat Purchases ReadyCell through MedTech Innovation on Advanced Medicine